These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Gold therapy. II. Historical, chemical, pharmacological and biological profile of anti-arthritic gold compounds. Kean WF; Gerecz E; Hogan MG Singapore Med J; 1987 Apr; 28(2):117-25. PubMed ID: 3155422 [No Abstract] [Full Text] [Related]
7. The effect of longterm treatment with auranofin and gold sodium thiomalate on immune function in the dog. Bloom JC; Thiem PA; Halper LK; Saunders LZ; Morgan DG J Rheumatol; 1988 Mar; 15(3):409-17. PubMed ID: 3132555 [TBL] [Abstract][Full Text] [Related]
8. Adverse reactions to gold compounds. Cohen MA Adverse Drug React Acute Poisoning Rev; 1988; 7(4):163-78. PubMed ID: 3149142 [No Abstract] [Full Text] [Related]
9. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate. Iqbal MS; Saeed M; Taqi SG Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049 [TBL] [Abstract][Full Text] [Related]
10. [Mechanism of action of gold compounds]. Vischer TL Wien Klin Wochenschr Suppl; 1984; 156():17-8. PubMed ID: 6442050 [TBL] [Abstract][Full Text] [Related]
11. The paradox of gold compounds: activators or inhibitors? Parente JE; Wong K; Davis P J Rheumatol; 1986 Oct; 13(5):846-8. PubMed ID: 3102725 [No Abstract] [Full Text] [Related]
12. [Indications and contraindications for systemic gold therapy]. Schattenkirchner M Wien Klin Wochenschr Suppl; 1984; 156():3-7. PubMed ID: 6442054 [TBL] [Abstract][Full Text] [Related]
13. An update on methotrexate. Braun J; Rau R Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092 [TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetics of parenteral and oral gold compounds. Gottlieb NL J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498 [TBL] [Abstract][Full Text] [Related]